Senior insider sale
Chief Medical Officer at GALECTIN THERAPEUTICS INC — senior position signals high conviction
$832.4K
148.68K shares
What this filing means
JAMIL KHURRAM plans to sell 148.68K shares of GALECTIN THERAPEUTICS INC valued at approximately $832.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/31/2025ACC: 0001972481-25-000326
Officer· Chief Medical Officer
Since Aug 2024
148.68K
Shares to sell
$832.4K
Approx. market value
65K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Option Exercise
Cash
1/23/2025
65KTotal acquired65K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/23/2025 | Option Exercise Cash | 65K | — |
| Total | 65K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
19.44K
Market value
$136.9K
12/17/2025
—Completed
Units to sell
121.12K
Market value
$662.2K
11/13/2025
Planned — Approximate Date
NasdaqPlanned
Units to sell
8.13K
Market value
$33.3K
12/31/2025
Total
Units
148.68K
Value
$832.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/17/2025 | 19.44K | $136.9K | — | Completed |
11/13/2025 | 121.12K | $662.2K | — | Completed |
| Planned — Approximate Date | ||||
12/31/2025 | 8.13K | $33.3K | Nasdaq | Planned |
| Total | 148.68K | $832.4K | ||